Quarter Financials
Vertex Pharmaceuticals Incorporated (VRTX)
$276.78
-6.67 (-2.35%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | 811 | 762 | 770 | 852 | 67 | 653 | 604 | 667 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | 4,773 | 3,963 | 3,201 | 2,431 | 1,579 | 1,512 | 859 | 254 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | -53 | -64 | -62 | -53 | -50 | -71 | -48 | -175 |
|---|
| Net PPE | 1,418 | 1,436 | 1,424 | 1,355 | 1,338 | 1,308 | 959 | 921 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | -134 | -184 | -121 | -118 | -246 | -119 | -117 | -121 |
|---|
| Intangible and Goodwill | 1,002 | 1,002 | 1,002 | 1,002 | 1,002 | 1,002 | 1,002 | 1,002 |
|---|